
Nordson (NDSN) Stock Forecast & Price Target
Nordson (NDSN) Analyst Ratings
Bulls say
Nordson's diverse business model, which includes advanced technology solutions and medical fluid solutions, has shown robust revenue growth, with the Advanced Technology Solutions segment reporting a 17.4% increase to $171 million and the Medical & Fluid Solutions segment achieving a 31.6% increase to $219 million, driven primarily by strategic acquisitions. Furthermore, the company reported a notable 13% increase in adjusted earnings per share, reaching $2.73 in fiscal Q3 2025, underscoring its strong operational performance. These positive financial results, along with improvements in demand across core markets, support an optimistic outlook for Nordson's stock in light of its continued revenue expansion and earnings growth.
Bears say
Nordson's Industrial Precision Solutions segment reported a revenue increase of only 0.5% year-over-year, with a significant organic decline of 2.0% driven by weaker demand in polymer processing. Additionally, the company experienced a sequential decline in backlog of approximately 5%, indicating potential challenges in sustaining future revenue growth. While EPS guidance reflects a modestly optimistic outlook, it fails to offset the growing concerns surrounding demand fluctuations and declining backlog across its segments.
This aggregate rating is based on analysts' research of Nordson and is not a guaranteed prediction by Public.com or investment advice.
Nordson (NDSN) Analyst Forecast & Price Prediction
Start investing in Nordson (NDSN)
Order type
Buy in
Order amount
Est. shares
0 shares